Kunihiro Matsuo Selected Research

Kunihiro Matsuo Research Topics

Disease

7	Myocardial Infarction 10/2022 - 01/2004
7	Coronary Artery Disease (Coronary Atherosclerosis) 06/2009 - 06/2003
6	Pathologic Constriction (Stenosis) 06/2009 - 10/2003
5	Coronary Restenosis 01/2008 - 10/2003
3	Acute Coronary Syndrome 01/2023 - 01/2005
3	ST Elevation Myocardial Infarction 09/2022 - 03/2022
3	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 03/2011
3	Thrombosis (Thrombus) 12/2012 - 01/2009
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2006 - 10/2003
2	Liver Neoplasms (Liver Cancer) 01/2018 - 08/2015
2	Hypertension (High Blood Pressure) 01/2012 - 02/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2022
1	Shock 08/2022
1	Heart Arrest (Cardiac Arrest) 08/2022
1	Thrombocytopenia (Thrombopenia) 08/2015
1	Out-of-Hospital Cardiac Arrest 12/2012
1	Neoplasms (Cancer) 08/2012
1	Diabetes Mellitus 01/2012
1	Pericarditis 03/2011
1	Stable Angina 01/2008
1	Inflammation (Inflammations) 02/2007
1	Atrial Fibrillation 02/2007
1	Heart Failure 01/2006
1	Hyperlipidemias (Hyperlipidemia) 01/2005
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2004
1	Cardiomegaly (Heart Hypertrophy) 02/2004
1	Atherosclerosis 01/2004
1	Neointima 10/2003
1	Hyperplasia 10/2003

Drug/Important Bio-Agent (IBA)

5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2009 - 02/2004
3	ChemokinesIBA 01/2008 - 10/2003
3	Chemokine ReceptorsIBA 01/2008 - 10/2003
2	SuspensionsIBA 08/2015 - 03/2011
2	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 03/2011
2	Iodized OilIBA 08/2015 - 08/2012
2	oxidized low density lipoproteinIBA 06/2009 - 02/2007
2	LDL CholesterolIBA 06/2009 - 01/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 02/2007 - 01/2006
2	C-Reactive ProteinIBA 02/2007 - 01/2006
2	LipidsIBA 04/2006 - 01/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2006 - 06/2003
2	Angiotensin Receptor AntagonistsIBA 01/2006 - 03/2005
2	Cell Adhesion MoleculesIBA 01/2004 - 01/2004
1	Nitroglycerin (Dynamite)FDA LinkGeneric 10/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022
1	Oxygen (Dioxygen)IBA 08/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	PowdersIBA 08/2015
1	Alanine (L-Alanine)FDA Link 08/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2015
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2012
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2012
1	Glycated Serum AlbuminIBA 01/2012
1	Epirubicin (Ellence)FDA LinkGeneric 03/2011
1	EmulsionsIBA 03/2011
1	Ethiodized Oil (Ethiodol)FDA Link 03/2011
1	AdiponectinIBA 06/2009
1	Hemoglobins (Hemoglobin)IBA 06/2009
1	HDL CholesterolIBA 06/2009
1	Triglycerides (Triacylglycerol)IBA 06/2009
1	AnticoagulantsIBA 01/2009
1	Warfarin (Coumadin)FDA LinkGeneric 01/2009
1	MetalsIBA 01/2008
1	Sirolimus (Rapamycin)FDA Link 01/2008
1	Platelet Activating FactorIBA 02/2007
1	Losartan (Cozaar)FDA LinkGeneric 01/2007
1	Valsartan (Vals)FDA Link 01/2007
1	Angiotensin II Type 1 Receptor BlockersIBA 03/2006
1	Carvedilol (Coreg)FDA LinkGeneric 01/2006
1	Arginine (L-Arginine)FDA Link 01/2006
1	CXCR ReceptorsIBA 01/2006
1	CC ChemokinesIBA 01/2006
1	CalciumIBA 02/2004
1	LigandsIBA 01/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 10/2003
1	CXC ChemokinesIBA 10/2003
1	InterferonsIBA 10/2003
1	Monocyte Chemoattractant ProteinsIBA 10/2003
1	EnzymesIBA 10/2003

Therapy/Procedure

7	Therapeutics 09/2022 - 01/2005
5	Stents 03/2011 - 01/2005
1	Resuscitation 01/2023
1	Percutaneous Coronary Intervention 03/2022
1	Drug Therapy (Chemotherapy) 08/2015
1	Thrombolytic Therapy 12/2012
1	Electrodes (Electrode) 03/2011
1	Renal Dialysis (Hemodialysis) 01/2004